-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Claritev, Lowers Price Target to $38

Benzinga·02/24/2026 16:23:34
Listen to the news
Guggenheim analyst Jason Cassorla maintains Claritev (NYSE:CTEV) with a Buy and lowers the price target from $43 to $38.